Neuroactive steroid treatment modulates myelin lipid profile in diabetic peripheral neuropathy

Journal of Steroid Biochemistry and Molecular Biology

Volumn 143, Issue , 2014, Pages 115-121

  Mitro, Nico ^a   Cermenati, Gaia ^a   Brioschi, Elisabetta ^a   Abbiati, Federico ^a   Audano, Matteo ^a   Giatti, Silvia ^a   Crestani, Maurizio ^a   De Fabiani, Emma ^a   Azcoitia, Inigo ^b   Garcia Segura, Luis Miguel ^c   Caruso, Donatella ^a   Melcangi, Roberto Cosimo ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^c INSTITUTO CAJAL   (Spain)

Author keywords

Metabolites; Peripheral nerve; Progesterone; Streptozotocin; Testosterone

Indexed keywords

20ALPHA DIHYDROPROGESTERONE; ANDROSTANEDIOL; MYELIN; SATURATED FATTY ACID; ANABOLIC AGENT; BIOLOGICAL MARKER; GESTAGEN; LIPID; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FATTY ACID DESATURATION; FATTY ACID SYNTHESIS; GENE EXPRESSION PROFILING; LIPID COMPOSITION; LIPID STORAGE; LIPOGENESIS; MALE; MYELINATED NERVE; NEUROMODULATION; NEUROPROTECTION; NONHUMAN; PERIPHERAL NEUROPATHY; RAT; REAL TIME POLYMERASE CHAIN REACTION; SCIATIC NERVE; STREPTOZOTOCIN-INDUCED DIABETIC NEUROPATHY; ANIMAL; COMPLICATION; DIABETIC NEUROPATHIES; DRUG EFFECTS; EXPERIMENTAL DIABETES MELLITUS; GENETICS; LIQUID CHROMATOGRAPHY; METABOLISM; MYELIN SHEATH; PERIPHERAL NERVOUS SYSTEM DISEASES; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPRAGUE DAWLEY RAT; TANDEM MASS SPECTROMETRY;

20-ALPHA-DIHYDROPROGESTERONE; ANABOLIC AGENTS; ANDROSTANE-3,17-DIOL; ANIMALS; BIOLOGICAL MARKERS; CHROMATOGRAPHY, LIQUID; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEUROPATHIES; LIPIDS; MALE; MYELIN SHEATH; PERIPHERAL NERVOUS SYSTEM DISEASES; PROGESTINS; RATS; RATS, SPRAGUE-DAWLEY; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SCIATIC NERVE; TANDEM MASS SPECTROMETRY;

EID: 84896323618     PISSN: 09600760     EISSN: 18791220     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2014.02.015     Document Type: Article

References (42)

1. A.I. Vinik, T.S. Park, K.B. Stansberry, and G.L. Pittenger Diabetic neuropathies Diabetologia 43 8 2000 957 973 (Pubitemid 30655714)
2. J. Valls-Canals, M. Povedano, J. Montero, and J. Pradas Diabetic polyneuropathy. Axonal or demyelinating? Electromyogr. Clin. Neurophysiol. 42 1 2002 3 6 (Pubitemid 34130156)
3. R.A. Malik, S. Tesfaye, P.G. Newrick, D. Walker, S.M. Rajbhandari, I. Siddique, A.K. Sharma, A.J. Boulton, R.H. King, P.K. Thomas, and J.D. Ward Sural nerve pathology in diabetic patients with minimal but progressive neuropathy Diabetologia 48 3 2005 578 585 (Pubitemid 40487306)
4. W.H. Herman Diabetes epidemiology: guiding clinical and public health practice: the Kelly West Award Lecture 2006 Diabetes Care 30 7 2007 1912 1919 (Pubitemid 47036382)
5. S. Yagihashi Pathogenetic mechanisms of diabetic neuropathy: lessons from animal models J. Peripher. Nerv. Syst. 2 2 1997 113 132 (Pubitemid 127687136)
6. G.J. Biessels, N.A. Cristino, G.J. Rutten, F.P. Hamers, D.W. Erkelens, and W.H. Gispen Neurophysiological changes in the central and peripheral nervous system of streptozotocin-diabetic rats. Course of development and effects of insulin treatment Brain 122 Pt 4 1999 757 768 (Pubitemid 29158781)
7. P.J. Dyck, B.R. Zimmerman, T.H. Vilen, S.R. Minnerath, J.L. Karnes, J.K. Yao, and J.F. Poduslo Nerve glucose, fructose, sorbitol, myo-inositol, and fiber degeneration and regeneration in diabetic neuropathy N. Engl. J. Med. 319 9 1988 542 548
8. G. Cermenati, F. Abbiati, S. Cermenati, E. Brioschi, A. Volonterio, G. Cavaletti, E. Saez, E. De Fabiani, M. Crestani, L.M. Garcia-Segura, R.C. Melcangi, D. Caruso, and N. Mitro Diabetes-induced myelin abnormalities are associated with an altered lipid pattern: protective effects of LXR activation J. Lipid Res. 53 2 2012 300 310
9. E. Leonelli, R. Bianchi, G. Cavaletti, D. Caruso, D. Crippa, L.M. Garcia-Segura, G. Lauria, V. Magnaghi, I. Roglio, and R.C. Melcangi Progesterone and its derivatives are neuroprotective agents in experimental diabetic neuropathy: a multimodal analysis Neuroscience 144 4 2007 1293 1304 (Pubitemid 46123820)
10. I. Roglio, R. Bianchi, S. Giatti, G. Cavaletti, D. Caruso, S. Scurati, D. Crippa, L.M. Garcia-Segura, F. Camozzi, G. Lauria, and R.C. Melcangi Testosterone derivatives are neuroprotective agents in experimental diabetic neuropathy Cell. Mol. Life Sci. 64 9 2007 1158 1168 (Pubitemid 46684552)
11. S. Veiga, E. Leonelli, M. Beelke, L.M. Garcia-Segura, and R.C. Melcangi Neuroactive steroids prevent peripheral myelin alterations induced by diabetes Neurosci. Lett. 402 1-2 2006 150 153 (Pubitemid 43766443)
12. D. Belelli, and J.J. Lambert Neurosteroids: endogenous regulators of the GABA(A) receptor Nat. Rev. Neurosci. 6 7 2005 565 575 (Pubitemid 40942823)
13. R.C. Melcangi, L.M. Garcia-Segura, and A.G. Mensah-Nyagan Neuroactive steroids: state of the art and new perspectives Cell. Mol. Life Sci. 65 5 2008 777 797
14. S.M. Paul, and R.H. Purdy Neuroactive steroids FASEB J. 6 6 1992 2311 2322
15. M. Pesaresi, O. Maschi, S. Giatti, L.M. Garcia-Segura, D. Caruso, and R.C. Melcangi Sex differences in neuroactive steroid levels in the nervous system of diabetic and non-diabetic rats Horm. Behav. 57 1 2010 46 55
16. D. Caruso, S. Scurati, O. Maschi, L. De Angelis, I. Roglio, S. Giatti, L.M. Garcia-Segura, and R.C. Melcangi Evaluation of neuroactive steroid levels by liquid chromatography-tandem mass spectrometry in central and peripheral nervous system: effect of diabetes Neurochem. Int. 52 4-5 2008 560 568
17. G. Cermenati, E. Brioschi, F. Abbiati, R.C. Melcangi, D. Caruso, and N. Mitro Liver, X receptors, nervous system and lipid metabolism J. Endocrinol. Invest. 36 6 2013 435 443
18. G. Cermenati, S. Giatti, G. Cavaletti, R. Bianchi, O. Maschi, M. Pesaresi, F. Abbiati, A. Volonterio, E. Saez, D. Caruso, R.C. Melcangi, and N. Mitro Activation of the liver X receptor increases neuroactive steroid levels and protects from diabetes-induced peripheral neuropathy J. Neurosci. 30 36 2010 11896 11901
19. R.C. Melcangi, S. Giatti, M. Pesaresi, D. Calabrese, N. Mitro, D. Caruso, and L.M. Garcia-Segura Role of neuroactive steroids in the peripheral nervous system Front. Endocrinol. (Lausanne) 2 2011 104
20. R.C. Melcangi, F. Celotti, P. Castano, and L. Martini Is the 5 alpha-reductase-3 alpha-hydroxysteroid dehydrogenase complex associated with the myelin in the peripheral nervous system of young and old male rats? Endocr. Regul. 26 3 1992 119 125 (Pubitemid 23208625)
21. R. Taguchi, and M. Ishikawa Precise and global identification of phospholipid molecular species by an Orbitrap mass spectrometer and automated search engine Lipid Search J. Chromatogr. A 1217 25 2010 4229 4239
22. T.M. Mayhew, and A.K. Sharma Sampling schemes for estimating nerve fibre size. I. Methods for nerve trunks of mixed fascicularity J. Anat. 139 Pt 1 1984 45 58 (Pubitemid 14052315)
23. T.M. Mayhew, and A.K. Sharma Sampling schemes for estimating nerve fibre size. II. Methods for unifascicular nerve trunks J. Anat. 139 Pt 1 1984 59 66 (Pubitemid 14052316)
24. E.R. Arbuthnott, I.A. Boyd, and K.U. Kalu Ultrastructural dimensions of myelinated peripheral nerve fibres in the cat and their relation to conduction velocity J. Physiol. 308 1980 125 157 (Pubitemid 11252745)
25. E.R. Arbuthnott, K.J. Ballard, I.A. Boyd, and K.U. Kalu Quantitative study of the non-circularity of myelinated peripheral nerve fibres in the cat J. Physiol. 308 1980 99 123 (Pubitemid 11252744)
26. R. Chrast, G. Saher, K.A. Nave, and M.H. Verheijen Lipid metabolism in myelinating glial cells: lessons from human inherited disorders and mouse models J. Lipid Res. 52 3 2010 419 434
27. I. Azcoitia, E. Leonelli, V. Magnaghi, S. Veiga, L.M. Garcia-Segura, and R.C. Melcangi Progesterone and its derivatives dihydroprogesterone and tetrahydroprogesterone reduce myelin fiber morphological abnormalities and myelin fiber loss in the sciatic nerve of aged rats Neurobiol. Aging 24 6 2003 853 860 (Pubitemid 37288858)
28. R.C. Melcangi, I. Azcoitia, M. Ballabio, I. Cavarretta, L.C. Gonzalez, E. Leonelli, V. Magnaghi, S. Veiga, and L.M. Garcia-Segura Neuroactive steroids influence peripheral myelination: a promising opportunity for preventing or treating age-dependent dysfunctions of peripheral nerves Prog. Neurobiol. 71 1 2003 57 66 (Pubitemid 37377936)
29. I. Roglio, R. Bianchi, S. Gotti, S. Scurati, S. Giatti, M. Pesaresi, D. Caruso, G.C. Panzica, and R.C. Melcangi Neuroprotective effects of dihydroprogesterone and progesterone in an experimental model of nerve crush injury Neuroscience 155 3 2008 673 685
30. M.E. Chavez-Delgado, U. Gomez-Pinedo, A. Feria-Velasco, M. Huerta-Viera, S.C. Castaneda, F.A. Toral, A. Parducz, S.L. Anda, J. Mora-Galindo, and J. Garcia-Estrada Ultrastructural analysis of guided nerve regeneration using progesterone- and pregnenolone-loaded chitosan prostheses J. Biomed. Mater. Res. Part B 74 1 2005 589 600 (Pubitemid 40917730)
31. K.J. Jones, T.J. Brown, and M. Damaser Neuroprotective effects of gonadal steroids on regenerating peripheral motoneurons Brain Res. Brain Res. Rev. 37 1-3 2001 372 382 (Pubitemid 34020745)
32. H.L. Koenig, M. Schumacher, B. Ferzaz, A.N. Thi, A. Ressouches, R. Guennoun, I. Jung-Testas, P. Robel, Y. Akwa, and E.E. Baulieu Progesterone synthesis and myelin formation by Schwann cells Science 268 5216 1995 1500 1503
33. R.C. Melcangi, V. Magnaghi, M. Galbiati, B. Ghelarducci, L. Sebastiani, and L. Martini The action of steroid hormones on peripheral myelin proteins: a possible new tool for the rebuilding of myelin? J. Neurocytol. 29 5-6 2000 327 339 (Pubitemid 32154516)
34. M.H. Verheijen, N. Camargo, V. Verdier, K. Nadra, A.S. de Preux Charles, J.J. Medard, A. Luoma, M. Crowther, H. Inouye, H. Shimano, S. Chen, J.F. Brouwers, J.B. Helms, M.L. Feltri, L. Wrabetz, D. Kirschner, R. Chrast, and A.B. Smit SCAP is required for timely and proper myelin membrane synthesis Proc. Nat. Acad. Sci. U.S.A. 106 50 2009 21383 21388
35. B. Garbay, A.M. Heape, F. Sargueil, and C. Cassagne Myelin synthesis in the peripheral nervous system Prog. Neurobiol. 61 3 2000 267 304 (Pubitemid 30155722)
36. A.G. Lee Lipid-protein interactions in biological membranes: a structural perspective Biochim. Biophys. Acta 1612 1 2003 1 40 (Pubitemid 36555684)
37. J.L. Nussbaum, N. Neskovic, and P. Mandel A study of lipid components in brain of the 'Jimpy' mouse, a mutant with myelin deficiency J. Neurochem. 16 3 1969 927 934
38. N.K. Detering, and M.A. Wells The non-synchronous synthesis of myelin components during early stages of myelination in the rat optic nerve J. Neurochem. 26 2 1976 253 257
39. G. Saher, B. Brugger, C. Lappe-Siefke, W. Mobius, R. Tozawa, M.C. Wehr, F. Wieland, S. Ishibashi, and K.A. Nave High cholesterol level is essential for myelin membrane growth Nat. Neurosci. 8 4 2005 468 475 (Pubitemid 41007564)
40. T.R. Pak, W.C. Chung, T.D. Lund, L.R. Hinds, C.M. Clay, and R.J. Handa The androgen metabolite 5alpha-androstane-3beta, 17beta-diol, is a potent modulator of estrogen receptor-beta1-mediated gene transcription in neuronal cells Endocrinology 146 1 2005 147 155 (Pubitemid 40051734)
41. K.W. Gee, M.B. Bolger, R.E. Brinton, H. Coirini, and B.S. McEwen Steroid modulation of the chloride ionophore in rat brain: structure-activity requirements, regional dependence and mechanism of action J. Pharmacol. Exp. Ther. 246 2 1988 803 812
42. C.A. Frye, K.R. Van Keuren, and M.S. Erskine Behavioral effects of 3 alpha-androstanediol. I: Modulation of sexual receptivity and promotion of GABA-stimulated chloride flux Behav. Brain Res. 79 1-2 1996 109 118 (Pubitemid 26308931)